Review
Open access
Oct 2026
Isavuconazole: Real-World Data and Clinical Considerations for Pediatric Patients.
Isavuconazole (ISAV) is a broad-spectrum triazole antifungal approved for the treatment of invasive aspergillosis and mucormycosis and has recently received approval for use in children ≥1 year of age. Pediatric approval was based on limited registration data, underscoring the importance of real-world evidence to bette...
Lorenzo Chiusaroli, Danila Seidel, Daniel Ebrahimi-Fakhari et al.
· Paediatric drugs · 0 citations